As of 2024-10-06, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -85.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,132.64 mil USD. BLFS's TTM EBITDA according to its financial statements is -13.26 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 13.7x | 13.5x |
| Forward P/E multiples | 7.0x - 10.9x | 9.4x |
| Fair Price | (3.41) - (3.14) | (3.30) |
| Upside | -113.9% - -112.8% | -113.4% |
| Date | EV/EBITDA |
| 2024-10-04 | -85.39 |
| 2024-10-03 | -84.66 |
| 2024-10-02 | -84.52 |
| 2024-10-01 | -84.00 |
| 2024-09-30 | -87.13 |
| 2024-09-27 | -84.70 |
| 2024-09-26 | -84.10 |
| 2024-09-25 | -83.44 |
| 2024-09-24 | -86.26 |
| 2024-09-23 | -86.30 |
| 2024-09-20 | -89.67 |
| 2024-09-19 | -89.50 |
| 2024-09-18 | -82.54 |
| 2024-09-17 | -81.60 |
| 2024-09-16 | -88.59 |
| 2024-09-13 | -87.41 |
| 2024-09-12 | -84.49 |
| 2024-09-11 | -80.70 |
| 2024-09-10 | -82.50 |
| 2024-09-09 | -80.45 |
| 2024-09-06 | -82.78 |
| 2024-09-05 | -86.05 |
| 2024-09-04 | -85.88 |
| 2024-09-03 | -85.01 |
| 2024-08-30 | -90.05 |
| 2024-08-29 | -90.19 |
| 2024-08-28 | -88.21 |
| 2024-08-27 | -89.95 |
| 2024-08-26 | -90.40 |
| 2024-08-23 | -88.04 |
| 2024-08-22 | -85.08 |
| 2024-08-21 | -89.50 |
| 2024-08-20 | -88.97 |
| 2024-08-19 | -91.93 |
| 2024-08-16 | -89.95 |
| 2024-08-15 | -89.64 |
| 2024-08-14 | -90.12 |
| 2024-08-13 | -92.28 |
| 2024-08-12 | -89.78 |
| 2024-08-09 | -87.86 |
| 2024-08-08 | -79.13 |
| 2024-08-07 | -76.73 |
| 2024-08-06 | -79.62 |
| 2024-08-05 | -76.87 |
| 2024-08-02 | -78.82 |
| 2024-08-01 | -81.29 |
| 2024-07-31 | -83.58 |
| 2024-07-30 | -83.65 |
| 2024-07-29 | -82.82 |
| 2024-07-26 | -83.65 |